Nature Biotechnology
Engineered Cas13 variants with minimal collateral RNA targeting
Nature Biotechnology, Published online: 12 August 2022; doi:10.1038/s41587-022-01423-xThe application of CRISPR–Cas13 for targeted RNA degradation is hindered by the existence of collateral effects induced by Cas13. We screened hundred…